- Home
- PNFP vs ICLR Comparison
PNFP vs ICLR Comparison
Compare PNFP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNFP | ICLR |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.1B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | PNFP | ICLR |
|---|---|---|
| Price | $85.62 | $108.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $112.20 | ★ $194.38 |
| AVG Volume (30 Days) | 1.2M | ★ 3.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $163.66 | N/A |
| Revenue Next Year | $7.77 | N/A |
| P/E Ratio | ★ $12.24 | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $81.57 | $66.57 |
| 52 Week High | $120.39 | $211.00 |
Technical Indicators
Market Signals| Indicator | PNFP | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 33.98 | 38.19 |
| Support Level | $83.62 | $66.57 |
| Resistance Level | $90.97 | $153.72 |
| Average True Range (ATR) | 3.37 | 5.27 |
| MACD | -0.91 | 3.28 |
| Stochastic Oscillator | 16.66 | 81.59 |
Price Performance
Historical ComparisonAbout PNFP Pinnacle Financial Partners Inc.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.